DK1673370T3 - Krystallingsk form af linezolid - Google Patents

Krystallingsk form af linezolid

Info

Publication number
DK1673370T3
DK1673370T3 DK03769887T DK03769887T DK1673370T3 DK 1673370 T3 DK1673370 T3 DK 1673370T3 DK 03769887 T DK03769887 T DK 03769887T DK 03769887 T DK03769887 T DK 03769887T DK 1673370 T3 DK1673370 T3 DK 1673370T3
Authority
DK
Denmark
Prior art keywords
linezolid
crystalline form
preparation
relates
present
Prior art date
Application number
DK03769887T
Other languages
Danish (da)
English (en)
Inventor
Rao Dodda Mohan
Reddy Pingili Krishna
Original Assignee
Symed Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1673370(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd
Application granted granted Critical
Publication of DK1673370T3 publication Critical patent/DK1673370T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
DK03769887T 2003-10-16 2003-10-16 Krystallingsk form af linezolid DK1673370T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000336 WO2005035530A1 (fr) 2003-10-16 2003-10-16 Nouvelle forme cristalline du linezolid

Publications (1)

Publication Number Publication Date
DK1673370T3 true DK1673370T3 (da) 2009-12-07

Family

ID=34430675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03769887T DK1673370T3 (da) 2003-10-16 2003-10-16 Krystallingsk form af linezolid

Country Status (10)

Country Link
US (4) US7714128B2 (fr)
EP (3) EP2100884A1 (fr)
AT (1) ATE442364T1 (fr)
AU (1) AU2003278592A1 (fr)
DE (2) DE60329237D1 (fr)
DK (1) DK1673370T3 (fr)
ES (3) ES2331001T3 (fr)
HU (1) HUE051230T2 (fr)
PT (1) PT1673370E (fr)
WO (1) WO2005035530A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331001T3 (es) 2003-10-16 2009-12-18 Symed Labs Limited Forma cristalina de linezolid.
EP1737850B1 (fr) 2004-04-19 2007-10-03 Symed Labs Limited Nouveau procede pour preparer du linezolide et des composes associes
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
JP2008530028A (ja) 2005-02-24 2008-08-07 テバ ファーマシューティカル インダストリーズ リミティド リネゾリッド中間体の調製方法
DE602006001699D1 (de) * 2005-07-20 2008-08-21 Teva Pharma Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
IT1390957B1 (it) * 2008-07-07 2011-10-27 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
EP2033960A3 (fr) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Formule d'hydrate cristalline de linézolide et sels de linézolide
WO2009032294A2 (fr) * 2007-09-06 2009-03-12 Teva Pharmaceutical Industries Ltd. Procédés de préparation d'un intermédiaire du linézolide, hydroxyde de linezolide
WO2009140466A2 (fr) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Co-cristaux de linézolide
EP2493867A1 (fr) 2009-10-28 2012-09-05 Synthon BV Procédé de fabrication d'une forme cristalline a de linézolide
WO2011050826A1 (fr) * 2009-10-28 2011-05-05 Synthon B.V. Procédé de fabrication d'une forme cristalline de linézolide
EP2516408A1 (fr) 2009-12-26 2012-10-31 Alembic Pharmaceuticals Limited Procédé pour la préparation de linézolide
EP2603505A1 (fr) 2010-08-11 2013-06-19 Synthon BV Procédé pour fabriquer du linézolid
EP2603506A1 (fr) 2010-08-11 2013-06-19 Synthon BV Procédé pour fabriquer du linézolid
EP2611799A4 (fr) 2010-09-02 2014-01-29 Hetero Research Foundation Compositions pharmaceutiques de linézolide
CN102070548B (zh) * 2011-01-13 2012-12-26 浙江新东港药业股份有限公司 一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
WO2012114354A1 (fr) 2011-02-24 2012-08-30 Lee Pharma Limited Forme ii cristalline anhydre de linézolide
WO2012119653A1 (fr) 2011-03-09 2012-09-13 Synthon Bv Procédé de préparation de la forme cristalline a du linézolid
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
ITMI20111311A1 (it) * 2011-07-14 2013-01-15 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (fr) 2011-09-19 2013-05-23 Cadila Healthcare Limited Procédé de préparation de linézolide cristallin
WO2013093751A1 (fr) * 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Conditionnement pour le linézolide
EP2852580A1 (fr) 2012-01-24 2015-04-01 Jubilant Life Sciences Ltd. Procédé amélioré de préparation de la forme cristalline stable i du linézolide, pratiquement exempte de solvant résiduel
WO2013120496A1 (fr) 2012-02-14 2013-08-22 Pharmathen S.A. Procédé pour la préparation de linézolide sous forme cristalline et de sels de celui-ci
WO2013190559A1 (fr) * 2012-06-19 2013-12-27 Symed Labs Limited Procédés perfectionnés pour la préparation de forme cristalline iii du linézolide
US9492459B2 (en) * 2012-08-10 2016-11-15 Indoco Remedies Limited Pharmaceutical composition of linezolid
EP2917189B1 (fr) 2012-11-09 2016-08-17 Synthon BV Procédé de production de linézolide
WO2014118809A1 (fr) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Composition pharmaceutique comprenant du linézolide
WO2015068121A1 (fr) 2013-11-06 2015-05-14 Unimark Remedies Ltd. Procédé pour la préparation de la forme cristalline i de linézolide et ses compositions
CN105254580B (zh) * 2014-04-22 2018-01-02 江苏豪森药业集团有限公司 利奈唑胺晶型的制备方法
WO2016113751A1 (fr) * 2015-01-13 2016-07-21 Nosch Labs Private Limited Procédé de préparation de linézolide cristallin de forme iii
WO2018051360A1 (fr) * 2016-09-16 2018-03-22 Lee Pharma Limited Nouveau procédé de préparation de linézolide cristallin de forme iii
WO2019097242A1 (fr) 2017-11-16 2019-05-23 Persica Pharmaceuticals Ltd. Formulations de linézolide
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
WO2023062080A1 (fr) 2021-10-12 2023-04-20 Persica Pharmaceuticals Ltd. Traitement de la lombalgie

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583870A (en) * 1897-06-01 Wrench
DE2810349A1 (de) 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr) 1978-06-09 1982-12-03 Delalande Sa Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr) 1986-12-19 1989-04-28 Delalande Sa Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE9310451U1 (de) 1993-03-05 1994-06-30 Landis & Gyr Business Support Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
EP0615095B1 (fr) 1993-03-11 1997-05-07 Landis & Gyr Technology Innovation AG Commande de brûleur
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
KR100530297B1 (ko) 1996-04-11 2005-11-22 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
EP0890791A1 (fr) 1997-07-11 1999-01-13 Electrowatt Technology Innovation AG Dispositif de commande et de régulation pour un brûleur
EP1028940B1 (fr) * 1997-11-07 2007-04-18 Pharmacia & Upjohn Company LLC Procede de production d'oxazolidinones
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
DE10037585A1 (de) 2000-08-02 2002-02-14 Valeo Schalter & Sensoren Gmbh Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
PL365608A1 (en) 2000-08-14 2005-01-10 Teva Pharmaceutical Industries Ltd. Preparation of risperidone
US20030008012A1 (en) * 2001-02-05 2003-01-09 Pena Lorraine E. Composition for rectal delivery of an oxazolidinone antibacterial drug
WO2002085849A2 (fr) * 2001-04-20 2002-10-31 Pharmacia & Upjohn Company Procede de preparation d'oxazolidinones
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
ES2331001T3 (es) 2003-10-16 2009-12-18 Symed Labs Limited Forma cristalina de linezolid.
EP1737850B1 (fr) 2004-04-19 2007-10-03 Symed Labs Limited Nouveau procede pour preparer du linezolide et des composes associes
JP2007504173A (ja) 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
ATE429423T1 (de) 2004-07-20 2009-05-15 Symed Labs Ltd Neue zwischenprodukte für linezolid und verwandte verbindungen

Also Published As

Publication number Publication date
DE60329237D1 (de) 2009-10-22
US20060128703A1 (en) 2006-06-15
EP1673370B1 (fr) 2009-09-09
WO2005035530A1 (fr) 2005-04-21
ATE442364T1 (de) 2009-09-15
US20080090820A1 (en) 2008-04-17
EP2902386A1 (fr) 2015-08-05
EP2100884A1 (fr) 2009-09-16
US20080090824A1 (en) 2008-04-17
EP1673370A1 (fr) 2006-06-28
US20080091011A1 (en) 2008-04-17
US7718799B2 (en) 2010-05-18
ES2803516T3 (es) 2021-01-27
DE09163348T1 (de) 2010-01-07
HUE051230T2 (hu) 2021-03-01
EP2902386B1 (fr) 2020-04-08
ES2331001T3 (es) 2009-12-18
US7718800B2 (en) 2010-05-18
PT1673370E (pt) 2009-11-05
ES2331454T1 (es) 2010-01-05
US7714128B2 (en) 2010-05-11
US7732597B2 (en) 2010-06-08
AU2003278592A1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
DK1673370T3 (da) Krystallingsk form af linezolid
IS7007A (is) Kristallaform af asiþrómýsíni
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
IS3027B (is) Hraðuppleysandi samsetning af kalsíum viðtaka-virku efnasambandi
DK2363414T3 (da) Stedstyret modifikation af FVIII
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
NO20050132D0 (no) Vaksinesammensetning
SE0302305D0 (sv) Novel Compounds
DK1476162T3 (da) Kontrolleret syntese af ziprasidone
DK1603524T3 (da) Enzymholdig oral sammensætning med forbedret stabilitet
DK1414435T3 (da) Krystallinsk komposition indeholdende escitalopram
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1255754T3 (da) Linezolid-krystalform II
ATE364610T1 (de) Kristalline polymorphe form von irinotecan- hyrochlorid
DK1597232T3 (da) Ny krystallinsk modifikation af anhydratet af boscalid
DK1578774T3 (da) Oprensning af immunoglobuliner
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DK1250918T3 (da) Kosmetiske sammensætninger indeholdende ekstrakter af urbakterier
IS7195A (is) Ný vatnsfrí kristallaform af gabapentíni
EE05246B1 (et) Fungitsiididena kasutatavad oksasiin(ti)oonhendid
ATE328595T1 (de) Carvedilolpolymorph
DK1571900T3 (da) Generation af planter med ændret olieindhold
DK1373245T3 (da) Mellemprodukter til fremstilling af spinosyner
DK1592417T3 (da) Kombinationen af antidiabetiske lægemidler